Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Dry AMD With Geographic Atrophy”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Not applicableStudy completedNCT01890187
What this trial is testing

Repeatability and Reproducibility of Cirrus HD-OCT Measurements of Illumination Areas Under the Retinal Pigment Epithelium

Who this might be right for
Advanced Dry AMD With Geographic Atrophy
Carl Zeiss Meditec, Inc. 85
Testing effectiveness (Phase 2)WithdrawnNCT04358471
What this trial is testing

Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)

Who this might be right for
Dry Age-related Macular DegenerationGeographic AtrophyGene Therapy+1 more
Hemera Biosciences
Not applicableStudy completedNCT04084587
What this trial is testing

Visual Rehabilitation Through Acoustic Biofeedback With Retimax Vision Trainer in Patients With Advanced Age-related Macular Degeneration

Who this might be right for
Macular Degeneration AdvancedMacular Degeneration, SenileMacular Degeneration, Dry+2 more
University of Modena and Reggio Emilia 24
Early research (Phase 1)Study completedNCT01003691
What this trial is testing

Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy

Who this might be right for
Age-Related MaculopathyAge-Related MaculopathiesEye Diseases+2 more
Pfizer 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT02286089
What this trial is testing

Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Hoffmann-La Roche 24
Early research (Phase 1)Study completedNCT03144999
What this trial is testing

Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59

Who this might be right for
Dry Age-related Macular Degeneration
Janssen Research & Development, LLC 17
Testing effectiveness (Phase 2)Study completedNCT01344993
What this trial is testing

Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration

Who this might be right for
Dry Age Related Macular Degeneration
Astellas Institute for Regenerative Medicine 13
Testing effectiveness (Phase 2)Looking for participantsNCT06557460
What this trial is testing

A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)

Who this might be right for
Dry Age-related Macular DegenerationGeographic Atrophy
Regenerative Patch Technologies, LLC 24
Not applicableStudy completedNCT02463344
What this trial is testing

Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD

Who this might be right for
Age-Related Macular Degeneration
Astellas Institute for Regenerative Medicine 11
Testing effectiveness (Phase 2)UnknownNCT02590692
What this trial is testing

Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD

Who this might be right for
Dry Macular DegenerationGeographic Atrophy
Regenerative Patch Technologies, LLC 16
Testing effectiveness (Phase 2)Ended earlyNCT01577381
What this trial is testing

Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Age-Related Maculopathy
Pfizer 10